Ludwig Cancer Research

This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (June 2018) (Learn how and when to remove this message)

Ludwig Cancer Research

Founded	1971
Founder	Daniel K. Ludwig
Focus	Cancer Research
Headquarters	New York, NY, USA Zürich, Switzerland (European Office)
Area served	International
Key people	Chi Van Dang, MD, PhD, CEO and Scientific Director; Jonathan Skipper, PhD, President
Website	www.ludwigcancerresearch.org

Ludwig Cancer Research is an international community of scientists focused on cancer research, with the goal of preventing and controlling cancer.^[1] It encompasses the Ludwig Institute for Cancer Research, an international non-profit organization founded in 1971 by philanthropist Daniel K. Ludwig. The Institute is headquartered in New York City, with a European office located in Zürich. There are currently three Ludwig Branches: Ludwig Lausanne, Ludwig Oxford and Ludwig Princeton. In addition, there are six Ludwig Centers at leading institutions across the United States of America. Together, the Institute, Branches and Centers are known as Ludwig Cancer Research.

Since its founding in 1971, Ludwig Cancer Research has committed more than US$2.5 billion to cancer research. Ludwig Cancer Research focuses on both basic research and translational research, with specific emphasis on cell biology, genomics, immunology, neuroscience, prevention, cell signaling, stem cells, therapeutics, and tumor biology, as well as clinical trials and the design and development of small molecules with drug-like properties.^[2] Its researchers also focus on particular types of malignancy, including brain cancer, breast cancer, colon cancer, and melanoma.^[3]